Clinical Trials Directory

Trials / Completed

CompletedNCT01094301

Electrical Stimulation for the Treatment of Post-Stroke Shoulder Pain

A Prospective Multi-Center Pilot Study of the SPR™ System for the Treatment of Post-Stroke Shoulder Pain

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
28 (actual)
Sponsor
SPR Therapeutics, Inc. · Industry
Sex
All
Age
21 Years
Healthy volunteers
Not accepted

Summary

Post-stroke shoulder pain is defined as pain in the shoulder area that starts after a person has had a stroke. The SPR System is an investigational device that is being studied for the relief of post-stroke shoulder pain. The SPR System uses electrical stimulation and includes a Trial Stage (where a temporary system is used to see if the subject may benefit from this type of therapy) and may include an Implant Stage (where a small device is implanted under the skin in the chest). The SPR System delivers mild electrical stimulation to the shoulder where the subject feels pain. This research study will evaluate the effect of electrical stimulation on shoulder pain. Individuals who are over the age of 21, who had a stroke at least six months ago, who experience shoulder pain, and have tried other therapies for their shoulder pain, may be eligible to participate in the first stage of the SPR System. Subjects meeting the specified success criteria at the conclusion of the SPR Trial Stage who experience a return of pain within 6 months of completion of the Trial Stage may be eligible for the second stage (SPR Implant Stage). This research study lasts a little over 3 years and may include 17 visits to the study doctor and at least 8 telephone calls from study staff.

Conditions

Interventions

TypeNameDescription
DEVICEThe SPR SystemThe SPR System is an investigational two-staged device which delivers stimulation to the shoulder. Subjects with chronic post-stroke shoulder pain who meet eligibility criteria for the first stage (SPR Trial Stage) will receive a temporary Lead and External Stimulator. Subjects who qualify and who agreed to proceed will advance to the second stage (SPR Implant Stage) which uses an Implantable Pulse Generator (IPG) and Implantable Lead. Subjects will be followed until 36-months after IPG stimulation has been started.

Timeline

Start date
2010-04-01
Primary completion
2017-07-25
Completion
2017-07-25
First posted
2010-03-26
Last updated
2018-09-12
Results posted
2018-09-12

Locations

4 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01094301. Inclusion in this directory is not an endorsement.